Gene symbol: Adrb2

Organism: Rattus norvegicus

Summary: Enables several functions, including G-protein alpha-subunit binding activity; beta2-adrenergic receptor activity; and signaling receptor binding activity. Involved in several processes, including chemical synaptic transmission; positive regulation of ion transport; and response to steroid hormone. Located in several cellular components, including caveola; neuronal cell body membrane; and sarcolemma. Is active in glutamatergic synapse. Used to study cardiomyopathy (multiple); congestive heart failure; kidney disease (multiple); and lung disease (multiple). Biomarker of several diseases, including acute kidney failure; artery disease (multiple); congestive heart failure; polycystic ovary syndrome; and ulcerative colitis. Human ortholog(s) of this gene implicated in several diseases, including autoimmune disease (multiple); disease of metabolism (multiple); kidney failure (multiple); lung disease (multiple); and open-angle glaucoma (multiple). Orthologous to human ADRB2 (adrenoceptor beta 2). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 24176 AllianceGenome:RGD:2060


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0001505 Regulation of neurotransmitter levels
Process GO:0001659 Temperature homeostasis
Process GO:0001666 Response to hypoxia
Process GO:0001889 Liver development
Process GO:0001894 Tissue homeostasis
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001993 Regulation of systemic arterial blood pressure by norepinephrine-epinephrine
Process GO:0001997 Positive regulation of the force of heart contraction by epinephrine-norepinephrine
Process GO:0002021 Response to dietary excess
Process GO:0002024 Diet induced thermogenesis
Process GO:0002025 Norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure
Process GO:0002026 Regulation of the force of heart contraction
Process GO:0002028 Regulation of sodium ion transport
Process GO:0002029 Desensitization of G protein-coupled receptor signaling pathway
Process GO:0002032 Desensitization of G protein-coupled receptor signaling pathway by arrestin
Process GO:0002086 Diaphragm contraction
Process GO:0003008 System process
Process GO:0003009 Skeletal muscle contraction
Process GO:0003011 Involuntary skeletal muscle contraction
Process GO:0003012 Muscle system process
Process GO:0003013 Circulatory system process
Process GO:0003014 Renal system process
Process GO:0003016 Respiratory system process
Process GO:0003018 Vascular process in circulatory system
Process GO:0003044 Regulation of systemic arterial blood pressure mediated by a chemical signal
Process GO:0003057 Regulation of the force of heart contraction by chemical signal
Process GO:0003059 Positive regulation of the force of heart contraction by epinephrine
Process GO:0003073 Regulation of systemic arterial blood pressure
Process GO:0003085 Negative regulation of systemic arterial blood pressure
Process GO:0003099 Positive regulation of the force of heart contraction by chemical signal
Process GO:0003321 Positive regulation of blood pressure by epinephrine-norepinephrine
Process GO:0006139 Nucleobase-containing compound metabolic process
Process GO:0006351 Transcription, DNA-templated
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006366 Transcription by RNA polymerase II
Process GO:0006725 Cellular aromatic compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006810 Transport
Process GO:0006897 Endocytosis
Process GO:0006898 Receptor-mediated endocytosis
Process GO:0006936 Muscle contraction
Process GO:0006937 Regulation of muscle contraction
Process GO:0006939 Smooth muscle contraction
Process GO:0006940 Regulation of smooth muscle contraction
Process GO:0006941 Striated muscle contraction
Process GO:0006950 Response to stress
Process GO:0007154 Cell communication
Process GO:0007162 Negative regulation of cell adhesion
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007186 G protein-coupled receptor signaling pathway
Process GO:0007188 Adenylate cyclase-modulating G protein-coupled receptor signaling pathway
Process GO:0007189 Adenylate cyclase-activating G protein-coupled receptor signaling pathway
Process GO:0007190 Activation of adenylate cyclase activity
Process GO:0007267 Cell-cell signaling
Process GO:0007268 Chemical synaptic transmission
Process GO:0007275 Multicellular organism development
Process GO:0007565 Female pregnancy
Process GO:0007568 Aging
Process GO:0007585 Respiratory gaseous exchange by respiratory system
Process GO:0007610 Behavior
Process GO:0007611 Learning or memory
Process GO:0007612 Learning
Process GO:0008015 Blood circulation
Process GO:0008016 Regulation of heart contraction
Process GO:0008152 Metabolic process
Process GO:0008217 Regulation of blood pressure
Process GO:0008277 Regulation of G protein-coupled receptor signaling pathway
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008306 Associative learning
Process GO:0009058 Biosynthetic process
Process GO:0009059 Macromolecule biosynthetic process
Process GO:0009266 Response to temperature stimulus
Process GO:0009409 Response to cold
Process GO:0009605 Response to external stimulus
Process GO:0009611 Response to wounding
Process GO:0009628 Response to abiotic stimulus
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009894 Regulation of catabolic process
Process GO:0009896 Positive regulation of catabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009968 Negative regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0009991 Response to extracellular stimulus
Process GO:0010033 Response to organic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010467 Gene expression
Process GO:0010468 Regulation of gene expression
Process GO:0010469 Regulation of signaling receptor activity
Process GO:0010506 Regulation of autophagy
Process GO:0010508 Positive regulation of autophagy
Process GO:0010543 Regulation of platelet activation
Process GO:0010544 Negative regulation of platelet activation
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010638 Positive regulation of organelle organization
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010738 Regulation of protein kinase A signaling
Process GO:0010739 Positive regulation of protein kinase A signaling
Process GO:0010765 Positive regulation of sodium ion transport
Process GO:0010941 Regulation of cell death
Process GO:0010942 Positive regulation of cell death
Process GO:0010959 Regulation of metal ion transport
Process GO:0014070 Response to organic cyclic compound
Process GO:0016070 RNA metabolic process
Process GO:0016192 Vesicle-mediated transport
Process GO:0016239 Positive regulation of macroautophagy
Process GO:0016241 Regulation of macroautophagy
Process GO:0016525 Negative regulation of angiogenesis
Process GO:0017157 Regulation of exocytosis
Process GO:0018130 Heterocycle biosynthetic process
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019438 Aromatic compound biosynthetic process
Process GO:0022401 Negative adaptation of signaling pathway
Process GO:0022407 Regulation of cell-cell adhesion
Process GO:0022408 Negative regulation of cell-cell adhesion
Process GO:0022414 Reproductive process
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0022898 Regulation of transmembrane transporter activity
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0023058 Adaptation of signaling pathway
Process GO:0030154 Cell differentiation
Process GO:0030155 Regulation of cell adhesion
Process GO:0030193 Regulation of blood coagulation
Process GO:0030195 Negative regulation of blood coagulation
Process GO:0030278 Regulation of ossification
Process GO:0030279 Negative regulation of ossification
Process GO:0030500 Regulation of bone mineralization
Process GO:0030501 Positive regulation of bone mineralization
Process GO:0031099 Regeneration
Process GO:0031100 Animal organ regeneration
Process GO:0031279 Regulation of cyclase activity
Process GO:0031281 Positive regulation of cyclase activity
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031329 Regulation of cellular catabolic process
Process GO:0031331 Positive regulation of cellular catabolic process
Process GO:0031347 Regulation of defense response
Process GO:0031348 Negative regulation of defense response
Process GO:0031399 Regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031644 Regulation of nervous system process
Process GO:0031649 Heat generation
Process GO:0031667 Response to nutrient levels
Process GO:0031960 Response to corticosteroid
Process GO:0032091 Negative regulation of protein binding
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032102 Negative regulation of response to external stimulus
Process GO:0032409 Regulation of transporter activity
Process GO:0032411 Positive regulation of transporter activity
Process GO:0032412 Regulation of ion transmembrane transporter activity
Process GO:0032414 Positive regulation of ion transmembrane transporter activity
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032504 Multicellular organism reproduction
Process GO:0032570 Response to progesterone
Process GO:0032774 RNA biosynthetic process
Process GO:0032781 Positive regulation of ATP-dependent activity
Process GO:0032879 Regulation of localization
Process GO:0033043 Regulation of organelle organization
Process GO:0033554 Cellular response to stress
Process GO:0033574 Response to testosterone
Process GO:0033674 Positive regulation of kinase activity
Process GO:0033993 Response to lipid
Process GO:0034110 Regulation of homotypic cell-cell adhesion
Process GO:0034111 Negative regulation of homotypic cell-cell adhesion
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0034654 Nucleobase-containing compound biosynthetic process
Process GO:0034762 Regulation of transmembrane transport
Process GO:0034764 Positive regulation of transmembrane transport
Process GO:0034765 Regulation of ion transmembrane transport
Process GO:0034767 Positive regulation of ion transmembrane transport
Process GO:0035150 Regulation of tube size
Process GO:0035249 Synaptic transmission, glutamatergic
Process GO:0035296 Regulation of tube diameter
Process GO:0035809 Regulation of urine volume
Process GO:0035811 Negative regulation of urine volume
Process GO:0036293 Response to decreased oxygen levels
Process GO:0036294 Cellular response to decreased oxygen levels
Process GO:0040008 Regulation of growth
Process GO:0040014 Regulation of multicellular organism growth
Process GO:0040015 Negative regulation of multicellular organism growth
Process GO:0042060 Wound healing
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042311 Vasodilation
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042391 Regulation of membrane potential
Process GO:0042592 Homeostatic process
Process GO:0042698 Ovulation cycle
Process GO:0042981 Regulation of apoptotic process
Process GO:0043065 Positive regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043068 Positive regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043170 Macromolecule metabolic process
Process GO:0043243 Positive regulation of protein-containing complex disassembly
Process GO:0043244 Regulation of protein-containing complex disassembly
Process GO:0043266 Regulation of potassium ion transport
Process GO:0043268 Positive regulation of potassium ion transport
Process GO:0043269 Regulation of ion transport
Process GO:0043270 Positive regulation of ion transport
Process GO:0043393 Regulation of protein binding
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043462 Regulation of ATP-dependent activity
Process GO:0043549 Regulation of kinase activity
Process GO:0043627 Response to estrogen
Process GO:0044057 Regulation of system process
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044271 Cellular nitrogen compound biosynthetic process
Process GO:0044703 Multi-organism reproductive process
Process GO:0044706 Multi-multicellular organism process
Process GO:0044849 Estrous cycle
Process GO:0045444 Fat cell differentiation
Process GO:0045453 Bone resorption
Process GO:0045744 Negative regulation of G protein-coupled receptor signaling pathway
Process GO:0045761 Regulation of adenylate cyclase activity
Process GO:0045762 Positive regulation of adenylate cyclase activity
Process GO:0045765 Regulation of angiogenesis
Process GO:0045776 Negative regulation of blood pressure
Process GO:0045777 Positive regulation of blood pressure
Process GO:0045778 Positive regulation of ossification
Process GO:0045823 Positive regulation of heart contraction
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045926 Negative regulation of growth
Process GO:0045927 Positive regulation of growth
Process GO:0045932 Negative regulation of muscle contraction
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0045986 Negative regulation of smooth muscle contraction
Process GO:0046483 Heterocycle metabolic process
Process GO:0046849 Bone remodeling
Process GO:0046928 Regulation of neurotransmitter secretion
Process GO:0048511 Rhythmic process
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048545 Response to steroid hormone
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048609 Multicellular organismal reproductive process
Process GO:0048631 Regulation of skeletal muscle tissue growth
Process GO:0048633 Positive regulation of skeletal muscle tissue growth
Process GO:0048638 Regulation of developmental growth
Process GO:0048639 Positive regulation of developmental growth
Process GO:0048640 Negative regulation of developmental growth
Process GO:0048641 Regulation of skeletal muscle tissue development
Process GO:0048643 Positive regulation of skeletal muscle tissue development
Process GO:0048731 System development
Process GO:0048732 Gland development
Process GO:0048771 Tissue remodeling
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0050727 Regulation of inflammatory response
Process GO:0050728 Negative regulation of inflammatory response
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050818 Regulation of coagulation
Process GO:0050819 Negative regulation of coagulation
Process GO:0050865 Regulation of cell activation
Process GO:0050866 Negative regulation of cell activation
Process GO:0050873 Brown fat cell differentiation
Process GO:0050877 Nervous system process
Process GO:0050878 Regulation of body fluid levels
Process GO:0050879 Multicellular organismal movement
Process GO:0050881 Musculoskeletal movement
Process GO:0050890 Cognition
Process GO:0050896 Response to stimulus
Process GO:0050905 Neuromuscular process
Process GO:0051046 Regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051093 Negative regulation of developmental process
Process GO:0051094 Positive regulation of developmental process
Process GO:0051098 Regulation of binding
Process GO:0051100 Negative regulation of binding
Process GO:0051128 Regulation of cellular component organization
Process GO:0051130 Positive regulation of cellular component organization
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051338 Regulation of transferase activity
Process GO:0051339 Regulation of lyase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051349 Positive regulation of lyase activity
Process GO:0051384 Response to glucocorticoid
Process GO:0051588 Regulation of neurotransmitter transport
Process GO:0051716 Cellular response to stimulus
Process GO:0051924 Regulation of calcium ion transport
Process GO:0051928 Positive regulation of calcium ion transport
Process GO:0051930 Regulation of sensory perception of pain
Process GO:0051931 Regulation of sensory perception
Process GO:0060078 Regulation of postsynaptic membrane potential
Process GO:0060079 Excitatory postsynaptic potential
Process GO:0060249 Anatomical structure homeostasis
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060627 Regulation of vesicle-mediated transport
Process GO:0061008 Hepaticobiliary system development
Process GO:0061041 Regulation of wound healing
Process GO:0061045 Negative regulation of wound healing
Process GO:0061884 Regulation of mini excitatory postsynaptic potential
Process GO:0061885 Positive regulation of mini excitatory postsynaptic potential
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070167 Regulation of biomineral tissue development
Process GO:0070169 Positive regulation of biomineral tissue development
Process GO:0070482 Response to oxygen levels
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071453 Cellular response to oxygen levels
Process GO:0071456 Cellular response to hypoxia
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071548 Response to dexamethasone
Process GO:0071704 Organic substance metabolic process
Process GO:0071867 Response to monoamine
Process GO:0071869 Response to catecholamine
Process GO:0071875 Adrenergic receptor signaling pathway
Process GO:0071880 Adenylate cyclase-activating adrenergic receptor signaling pathway
Process GO:0071900 Regulation of protein serine/threonine kinase activity
Process GO:0071902 Positive regulation of protein serine/threonine kinase activity
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0090066 Regulation of anatomical structure size
Process GO:0090257 Regulation of muscle system process
Process GO:0090304 Nucleic acid metabolic process
Process GO:0090330 Regulation of platelet aggregation
Process GO:0090331 Negative regulation of platelet aggregation
Process GO:0097421 Liver regeneration
Process GO:0097659 Nucleic acid-templated transcription
Process GO:0097746 Blood vessel diameter maintenance
Process GO:0098815 Modulation of excitatory postsynaptic potential
Process GO:0098916 Anterograde trans-synaptic signaling
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:0099536 Synaptic signaling
Process GO:0099537 Trans-synaptic signaling
Process GO:0099565 Chemical synaptic transmission, postsynaptic
Process GO:0099601 Regulation of neurotransmitter receptor activity
Process GO:0110149 Regulation of biomineralization
Process GO:0110151 Positive regulation of biomineralization
Process GO:0120161 Regulation of cold-induced thermogenesis
Process GO:0120162 Positive regulation of cold-induced thermogenesis
Process GO:1900046 Regulation of hemostasis
Process GO:1900047 Negative regulation of hemostasis
Process GO:1901096 Regulation of autophagosome maturation
Process GO:1901098 Positive regulation of autophagosome maturation
Process GO:1901342 Regulation of vasculature development
Process GO:1901343 Negative regulation of vasculature development
Process GO:1901360 Organic cyclic compound metabolic process
Process GO:1901362 Organic cyclic compound biosynthetic process
Process GO:1901576 Organic substance biosynthetic process
Process GO:1901652 Response to peptide
Process GO:1901653 Cellular response to peptide
Process GO:1901654 Response to ketone
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1901861 Regulation of muscle tissue development
Process GO:1901863 Positive regulation of muscle tissue development
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1903034 Regulation of response to wounding
Process GO:1903035 Negative regulation of response to wounding
Process GO:1903169 Regulation of calcium ion transmembrane transport
Process GO:1903305 Regulation of regulated secretory pathway
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903522 Regulation of blood circulation
Process GO:1903524 Positive regulation of blood circulation
Process GO:1903530 Regulation of secretion by cell
Process GO:1904062 Regulation of cation transmembrane transport
Process GO:1904064 Positive regulation of cation transmembrane transport
Process GO:1904427 Positive regulation of calcium ion transmembrane transport
Process GO:1904502 Regulation of lipophagy
Process GO:1904504 Positive regulation of lipophagy
Process GO:1904645 Response to amyloid-beta
Process GO:1904646 Cellular response to amyloid-beta
Process GO:1905114 Cell surface receptor signaling pathway involved in cell-cell signaling
Process GO:1905664 Regulation of calcium ion import across plasma membrane
Process GO:1905665 Positive regulation of calcium ion import across plasma membrane
Process GO:1990845 Adaptive thermogenesis
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000181 Negative regulation of blood vessel morphogenesis
Process GO:2000273 Positive regulation of signaling receptor activity
Process GO:2000300 Regulation of synaptic vesicle exocytosis
Process GO:2000311 Regulation of AMPA receptor activity
Process GO:2000463 Positive regulation of excitatory postsynaptic potential
Process GO:2000969 Positive regulation of AMPA receptor activity
Process GO:2001141 Regulation of RNA biosynthetic process
Process GO:2001257 Regulation of cation channel activity
Process GO:2001259 Positive regulation of cation channel activity
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005737 Cytoplasm
Component GO:0005768 Endosome
Component GO:0005769 Early endosome
Component GO:0005794 Golgi apparatus
Component GO:0005886 Plasma membrane
Component GO:0005887 Integral component of plasma membrane
Component GO:0005901 Caveola
Component GO:0012505 Endomembrane system
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0016324 Apical plasma membrane
Component GO:0030054 Cell junction
Component GO:0030424 Axon
Component GO:0030425 Dendrite
Component GO:0031224 Intrinsic component of membrane
Component GO:0031226 Intrinsic component of plasma membrane
Component GO:0031410 Cytoplasmic vesicle
Component GO:0031982 Vesicle
Component GO:0032809 Neuronal cell body membrane
Component GO:0032991 Protein-containing complex
Component GO:0036477 Somatodendritic compartment
Component GO:0042383 Sarcolemma
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043025 Neuronal cell body
Component GO:0043197 Dendritic spine
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043235 Receptor complex
Component GO:0044297 Cell body
Component GO:0044298 Cell body membrane
Component GO:0044309 Neuron spine
Component GO:0044853 Plasma membrane raft
Component GO:0045121 Membrane raft
Component GO:0045177 Apical part of cell
Component GO:0045202 Synapse
Component GO:0071944 Cell periphery
Component GO:0097447 Dendritic tree
Component GO:0097708 Intracellular vesicle
Component GO:0098590 Plasma membrane region
Component GO:0098794 Postsynapse
Component GO:0098857 Membrane microdomain
Component GO:0098978 Glutamatergic synapse
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Function GO:0001540 Amyloid-beta binding
Function GO:0001664 G protein-coupled receptor binding
Function GO:0001965 G-protein alpha-subunit binding
Function GO:0004888 Transmembrane signaling receptor activity
Function GO:0004930 G protein-coupled receptor activity
Function GO:0004935 Adrenergic receptor activity
Function GO:0004939 Beta-adrenergic receptor activity
Function GO:0004941 beta2-adrenergic receptor activity
Function GO:0005102 Signaling receptor binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008179 Adenylate cyclase binding
Function GO:0008227 G protein-coupled amine receptor activity
Function GO:0015459 Potassium channel regulator activity
Function GO:0016247 Channel regulator activity
Function GO:0019899 Enzyme binding
Function GO:0019902 Phosphatase binding
Function GO:0019903 Protein phosphatase binding
Function GO:0019904 Protein domain specific binding
Function GO:0030165 PDZ domain binding
Function GO:0031711 Bradykinin receptor binding
Function GO:0031713 B2 bradykinin receptor binding
Function GO:0033218 Amide binding
Function GO:0035254 Glutamate receptor binding
Function GO:0035255 Ionotropic glutamate receptor binding
Function GO:0038023 Signaling receptor activity
Function GO:0042277 Peptide binding
Function GO:0042802 Identical protein binding
Function GO:0042803 Protein homodimerization activity
Function GO:0044877 Protein-containing complex binding
Function GO:0046983 Protein dimerization activity
Function GO:0051379 Epinephrine binding
Function GO:0051380 Norepinephrine binding
Function GO:0051721 Protein phosphatase 2A binding
Function GO:0060089 Molecular transducer activity
Function GO:0090722 Receptor-receptor interaction
Function GO:0097159 Organic cyclic compound binding
Function GO:0098772 Molecular function regulator activity
Function GO:0099106 Ion channel regulator activity
Function GO:1901338 Catecholamine binding

Pathway annotation


Category Term ID Term description
RCTM RNO-162582 Signal Transduction
RCTM RNO-199991 Membrane Trafficking
RCTM RNO-372790 Signaling by GPCR
RCTM RNO-373076 Class A/1 (Rhodopsin-like receptors)
RCTM RNO-375280 Amine ligand-binding receptors
RCTM RNO-388396 GPCR downstream signalling
RCTM RNO-390696 Adrenoceptors
RCTM RNO-392499 Metabolism of proteins
RCTM RNO-418555 G alpha (s) signalling events
RCTM RNO-500792 GPCR ligand binding
RCTM RNO-5653656 Vesicle-mediated transport
RCTM RNO-5688426 Deubiquitination
RCTM RNO-5689880 Ub-specific processing proteases
RCTM RNO-597592 Post-translational protein modification
RCTM RNO-8856825 Cargo recognition for clathrin-mediated endocytosis
RCTM RNO-8856828 Clathrin-mediated endocytosis
KEGG rno04020 Calcium signaling pathway
KEGG rno04022 cGMP-PKG signaling pathway
KEGG rno04024 cAMP signaling pathway
KEGG rno04080 Neuroactive ligand-receptor interaction
KEGG rno04261 Adrenergic signaling in cardiomyocytes
KEGG rno04923 Regulation of lipolysis in adipocytes
KEGG rno04924 Renin secretion
KEGG rno04970 Salivary secretion
KEGG rno05207 Chemical carcinogenesis - receptor activation

Expression profile of Adrb2 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 7.4331546
GSM2685202 MX2 tissue: Myocardium gender: female 7.8221283
GSM2685203 MX3 tissue: Myocardium gender: female 7.5623555
GSM2685204 MX4 tissue: Myocardium gender: male 7.665185
GSM2685205 DZ1 tissue: Myocardium gender: male 7.81914
GSM2685206 DZ2 tissue: Myocardium gender: male 8.108447
GSM2685207 DZ3 tissue: Myocardium gender: female 7.938677
GSM2685208 DZ4 tissue: Myocardium gender: female 7.876981
GSM2685209 JJ1 tissue: Myocardium gender: male 7.221099
GSM2685210 JJ2 tissue: Myocardium gender: female 7.06803
GSM2685211 JJ3 tissue: Myocardium gender: female 8.025478
GSM2685212 JJ4 tissue: Myocardium gender: male 7.400729
GSM2685213 NG1 tissue: Myocardium gender: male 7.378673
GSM2685214 NG2 tissue: Myocardium gender: female 7.4658155
GSM2685215 NG3 tissue: Myocardium gender: male 7.546251
GSM2685216 NG4 tissue: Myocardium gender: female 7.514217
GSM2685217 YL1 tissue: Myocardium gender: male 7.59112
GSM2685218 YL2 tissue: Myocardium gender: male 7.580214
GSM2685219 YL3 tissue: Myocardium gender: female 7.817468
GSM2685220 YL4 tissue: Myocardium gender: female 7.889091
GSM2685221 QC1 tissue: Myocardium gender: male 7.199372
GSM2685222 QC2 tissue: Myocardium gender: male 7.068463
GSM2685223 QC3 tissue: Myocardium gender: female 7.77114
GSM2685224 QC4 tissue: Myocardium gender: female 7.2625546

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 17.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 20.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 23.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 29.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 38.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 26.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 24.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 55.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 23.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 26.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 21.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 37.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 22.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 17.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 33.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 14.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.651065
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.866437
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.925162
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.024575
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.933958
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.882261

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 5.4
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 5.359
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 6.849
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 4.87
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 5.084

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 6.34479248
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 6.192604394
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 5.51741225

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 184.15
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 214.10000000000002
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 167.85000000000002
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 176.8
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 166.75
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 134.25
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 182.6
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 131.9
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 85.55
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 133.75
GSM27494 CTL_a (control, 1st replicate) 118.7
GSM27495 CTL_b (control, 2nd replicate) 135.6
GSM27496 CTL_c (control, 3rd replicate) 84.05
GSM27497 CTL_d (control, 4th replicate) 114.9
GSM27498 CTL_e (control, 5th replicate) 98.75
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 209.45
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 169.05
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 173.75
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 191.3
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 134.45
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 174.5
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 176.75
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 141.05
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 113.94999999999999
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 117.05
GSM27509 ISCH_a (ischemia, 1st replicate) 288.5
GSM27510 ISCH_b (ischemia, 2nd replicate) 190.60000000000002
GSM27511 ISCH_c (ischemia, 3rd replicate) 173.64999999999998
GSM27512 ISCH_d (ischemia, 4th replicate) 102.1
GSM27513 ISCH_e (ischemia, 5th replicate) 146.0

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 78.6
GSM30791 baseline control 02 male, 275-300g 78.3
GSM30792 baseline control 03 male, 275-300g 94.2
GSM30793 baseline control 04 male, 275-300g 56.5
GSM30794 baseline control 05 male, 275-300g 78.8
GSM30795 baseline control 06 male, 275-300g 52.0
GSM30796 baseline control 07 male, 275-300g 70.2
GSM30797 baseline control 08 male, 275-300g 83.9
GSM30798 baseline control 09 male, 275-300g 122.7
GSM30799 pain 01 76.2
GSM30800 pain 02 118.4
GSM30801 pain 03 146.4
GSM30802 pain 04 46.5
GSM30803 pain 05 96.8
GSM30804 FC 01 56.5
GSM30805 FC 02 114.4
GSM30806 FC 03 77.6
GSM30807 FC 04 74.1
GSM30808 FC 05 52.2
GSM30809 IFC 01 85.2
GSM30810 IFC 02 76.5
GSM30811 IFC 03 84.7
GSM30812 IFC 04 87.9
GSM30813 IFC 05 99.7
GSM99800 isoflurane 01 male, 275-300g 65.9
GSM99801 isoflurane 02 male, 275-300g 67.7
GSM99802 isoflurane 03 male, 275-300g 100.4
GSM99803 isoflurane 04 male, 275-300g 58.8
GSM99804 isoflurane 05 male, 275-300g 108.8

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 29.5042
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 32.7996
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 21.6761
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 22.0974
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 30.7793
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 25.8622
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 80.8186
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 48.4255
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 27.8181

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 5.0341
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 5.31329
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 4.77833
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 5.16564
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 4.98712
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 5.58681
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 4.86275
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 5.01311
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 5.06324
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 5.17883
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 5.01076
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 4.88791
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 4.96663
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 4.90339
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 5.01006
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 4.57976

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.950662
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.936746
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.532094
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.07383
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.892442
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.671268
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.034956
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.714022
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.795219
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.139678
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.947352
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.76711
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.713939
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.019131
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.732324
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.972802
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.677913
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.621426
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.656792
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.735319
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.966024
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.178961
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.7779
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.114075
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.785674
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.875581
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.455228
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.299858
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.189463
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.098685
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.704109
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.531289
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.676026
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.367124
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.137523
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.597669
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.343946
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.812819
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.826115
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.696043
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.052832
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.82534
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.166267
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.783454
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.733254

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 9.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 8.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 21.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 14.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 14.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 19.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 16.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 20.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 10.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 20.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 18.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 19.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 20.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 16.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 15.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 15.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 17.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 11.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 14.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 18.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 17.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 20.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 11.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 17.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 19.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 6.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 14.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 8.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 24.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 17.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 13.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 23.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 21.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 23.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 17.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 5.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 1.400639
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 0.907161
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 2.001517
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 2.031317

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.0265
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.0532
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.152
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 -0.126
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 0.000655
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.0676
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.0766
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.0791
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.0892
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.164
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.0137
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.136

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 24.650000000000002
GSM5121 Isoflurane single exposure control-2 25.1
GSM5122 Isoflurane single exposure control-3 23.150000000000002
GSM5124 Isoflurane single exposure 1 hr-1 20.85
GSM5126 Isoflurane single exposure 1 hr-2 15.95
GSM5127 Isoflurane single exposure 2 hr-1 19.8
GSM5130 Isoflurane single exposure 2 hr-2 23.6
GSM5131 Isoflurane single exposure 2 hr-3 16.35

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 6.095921476
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.832268547
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 6.090904036
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.944370266
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 6.373300843
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.910635484
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.346543711
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 6.382161539
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 6.071606078
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 6.418697214
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.87940909
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.696616067
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 6.274577629
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 6.30409654
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.796625051
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 6.161665354
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.67898358
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.522700145
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.712537951
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.865920454
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 6.132442156
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 6.082763151
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 6.222767648
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 6.319669444

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.670769
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.358518500000001
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.5779585
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.3892109999999995
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.358511
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.405114
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.385229000000001
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.410648999999999
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.473669
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.4407825
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.4004895
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.5145465
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.431061
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.477095
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.36741
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.4492080000000005
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.373837
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.407669
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.377639500000001
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.359013
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.3218265
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.492093000000001
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.436133
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.3907905

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 653.1045
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 556.39465

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 50.98746216
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 124.1455649
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 189.0502501
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 99.31904746
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 130.4740892
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 85.00877848
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 78.88709873
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 75.18206734
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 132.5102725
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 126.4166438
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 129.3288493
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 52.39712935
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 142.6179416
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 110.0850841

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 6.095921476
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.832268547
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 6.090904036
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.944370266
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 6.373300843
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.910635484
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.346543711
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 6.382161539
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 6.071606078
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 6.418697214
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.87940909
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.696616067
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 6.274577629
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 6.30409654
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.796625051
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 6.161665354
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.67898358
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.522700145
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.712537951
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.865920454
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 6.132442156
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 6.082763151
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 6.222767648
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 6.319669444
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 50.98746216
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 124.1455649
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 189.0502501
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 99.31904746
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 130.4740892
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 85.00877848
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 78.88709873
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 75.18206734
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 132.5102725
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 126.4166438
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 129.3288493
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 52.39712935
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 142.6179416
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 110.0850841

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 22.650000000000002
GSM5084 Control 2 23.9
GSM5085 Control 3 24.75
GSM5086 Control 4 32.6
GSM5087 Control 5 32.2
GSM5090 Control 6 27.3
GSM5105 Control 7 29.150000000000002
GSM5106 Control 8 28.65
GSM5107 Control 9 25.85
GSM5108 Halothane 10 exposure-1 20.5
GSM5109 Halothane 10 exposures-2 24.25
GSM5110 Halothane 10 exposures-3 26.099999999999998
GSM5111 Halothane 5 exposures-1 29.2
GSM5112 Halothane 5 exposures-2 31.200000000000003
GSM5113 Halothane 5 exposures-3 27.4
GSM5114 Isoflurane 10 exposures-1 21.05
GSM5115 Isoflurane 10 exposures-2 31.65
GSM5116 Isoflurane 10 exposures-3 30.8
GSM5117 Isoflurane 5 exposures-1 32.75
GSM5118 Isoflurane 5 exposures-2 27.799999999999997
GSM5119 Isoflurane 5 exposures-3 27.6
GSM11379 Control 10 23.55
GSM11380 Control 11 26.6
GSM11381 Control 12 26.4

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 25.1505
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 63.1868